This suggests that the residual subpopulations may consist of regenerated normal CD34−CD10−CD19+ B cells following induction therapy, whereas the residual subpopulations may consist of CD34+CD10− ALL cells following induction therapy. This evidence concerns the gene MME and acute lymphoblastic leukemia.